Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011489

Chief Medical Officer gave up 818 shares (to pay taxes)

  • Chief Medical Officer acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2019-02-16 Option exercise +2,750 8,013 D: show line 1 in the form
Bowden Christopher Chief Medical Officer 2019-02-19 Shares withheld for taxes −818 $58.03 $47,469 7,195 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2019-02-16 Option exercise · Restricted stock unit −2,750 5,500 D: show line 3 in the form
Loading xslF345X03/doc4.xml…